Ir para o conteúdo principal

Creative Medical Technology (NASDAQ: CELZ) — Perfil da empresa, notícias e dados financeiros

Logo de Creative Medical Technology
CELZ Creative Medical Technology
Creative Medical Technology primary media
Perfil da empresa

Creative Medical Technology

Creative Medical Technology (NASDAQ:CELZ) focuses on the development of regenerative medical applications aimed at treating conditions related to urology, neurology, orthopedics, and cardiology. Their comprehensive approach integrates novel stem cell therapies and biologics to advance the treatment of various diseases and injuries. With several significant projects underway, Creative Medical Technology is dedicated to leveraging state-of-the-art scientific discoveries to improve patient outcomes and quality of life. Their objectives are deeply rooted in innovation, with a strong commitment to research and development as the cornerstone of their strategy to address unmet medical needs.

Resumo

Public USParticipação acionária
1998Ano de fundação
4Funcionários
Phoenix, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
Phoenix, US

Produtos e/ou serviços de Creative Medical Technology

  • Stem cell therapies for treating erectile dysfunction, offering hope for regaining sexual function.
  • Immuno-stimulation therapy aimed at enhancing the body's natural defenses against various diseases.
  • AmnioStem product, utilizing amniotic fluid stem cells to support tissue regeneration and healing.
  • Epidural stimulation technology for recovery of motor functions in patients with spinal cord injuries.
  • OvaStem therapy for treating premature ovarian failure, aimed at restoring ovarian function.
  • Platelet-rich plasma (PRP) therapy, enhancing the body’s natural healing process in orthopedic conditions.

equipe executiva do Creative Medical Technology

  • Timothy WarbingtonCo-Founder, Chairman, President & CEO
  • Donald F. DickersonSenior VP, CFO & Director

Principais indicadores financeiros

Resultados divulgados pela Creative Medical Technology, em USD.

Cap. de mercado
5,5 mi
Receita (TTM)
3 mil
P/L
—
LPA (diluído, TTM)
-2.1
Dividend yield
—
Margem de lucro
0.0%
Receita e lucro anuais da Creative Medical Technology
Fim do ano fiscalReceitaResultado operacionalLucro líquido
6 mil-6,1 mi-6 mi
11 mil-5,7 mi-5,5 mi
9 mil-5,6 mi-5,3 mi
88,6 mil-10,2 mi-10,1 mi